Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Delphia Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Delphia Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Genesis Molecular AI Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Genesis Molecular AI, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Evolyra Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Evolyra Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Eikonizo Therapeutics, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Eikonizo Therapeutics, Inc., covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Duo Oncology Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Duo Oncology, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Defand Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Defand Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
CTCELLS Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of CTCELLS, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Click Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Click Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Beren Therapeutics PBC Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Beren Therapeutics PBC, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
8 min read
Avilar Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Avilar Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
EndoCyclic Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of EndoCyclic Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.
Latest Hotspot
9 min read
Crosspoint Therapeutics Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
18 August 2026
A 2026 BD opportunity scan of Crosspoint Therapeutics, covering pipeline ownership, development stage, evidence package, IP risk, deal precedents, financial signals and outreach rationale using PatSnap MCP workflows.